We have evaluated the muscarinic acetylcholine family of G protein-coupled receptors (mAChRs) for their oncogenic potential. These receptors are preferentially expressed in postmitotic cells, transducing signals specified by their endogenous agonist, the neurotransmitter acetylcholine. Cells transfected with individual human mAChR genes were morphologically indistinguishable from parental NIH 3T3 cells in the absence of agonist. In contrast, when cultures were supplemented with carbachol, a stable analog of acetylcholine, foci of transformation readily appeared in ml, m3, or m5 but not in m2 or m4 mAChRs transfectants. Receptor expression was verified by ligand binding and was similar for each transfected culture. Transformation was dose-dependent and required only low levels of receptor expression. In transformation-competent cells, agonist induced phosphatidylinositol hydrolysis, whereas in m2 or m4 transfectants, receptors were coupled to the inhibition of adenylyl cyclase. These findings demonstrate that mAChRs linked to phosphatidylinositol hydrolysis can act as conditional oncogenes when expressed in cells capable of proliferation.
Receptors for polypeptides, such as epidermal growth factor and platelet-derived growth factor, can induce cellular transformation when constitutively activated (1) (2) (3) (4) . Structural mutations or unregulated availability of ligand are mechanisms known to account for their transforming activity. These receptors are prototypes of a class that mediate signal transduction by virtue of an intrinsic protein-tyrosine kinase activity (2, 5, 6) . When the mas oncogene was discovered, a class of cell-surface receptors lacking protein-tyrosine kinase domains was also implicated in cellular transformation. The mas oncogene product has a structural motif characteristic of receptors that mediate signal transduction by coupling to GTP-binding proteins (G proteins) (7) . Although mas has a weak focus-inducing activity in vitro, cells transfected with this gene are highly tumorigenic in nude mice (7) . More recently, G protein-coupled serotonin receptors have been shown to convert fibroblasts to a tumorigenic state (8) . Because in these latter cases exogenous ligand is not required for transformation, either these genes encode aberrant receptors or endogenous ligands are responsible for their activation. Thus, ligand independence has limited the study of the mechanism by which these receptors mediate transformation.
In the present study, we have directly tested the hypothesis that normal G-protein-coupled receptors can induce agonistdependent neoplastic transformation. We chose a family of cell-surface neurotransmitter receptors, human muscarinic acetylcholine receptors (mAChRs), which possess sequence homology with both mas and the serotonin receptor (9) (10) (11) (12) . Muscarinic receptors are preferentially expressed in neurons and other postmitotic cells, and they transduce signals specified by their endogenous agonist, the neurotransmitter acetylcholine. The mAChR family consists of five distinct but highly homologous subtypes (ml-mS), which are encoded by five separate genes (9) (10) (11) (12) . Individual mAChRs have functional differences when expressed by cultured cells. Oddnumbered mAChRs potently stimulate phosphatidylinositol (PtdIns) metabolism, arachidonic acid release, and open Ca2+-dependent potassium channels by coupling with a pertussis toxin insensitive G protein. m2 and m4 mAChRs couple to a pertussis toxin-sensitive G protein to inhibit adenylyl cyclase (13) (14) (15) . Depending upon assay conditions, ml, m3, and m5 mAChRs have been linked to both increases (16) and decreases (17) in mitogenesis.
MATERIALS AND METHODS
Transfection. Plasmid DNA transfection of NIH 3T3 (18) cells was performed by the calcium phosphate precipitation technique, as modified by Wigler et al. (19) . Mass populations expressing the transfected gene were selected for ability to grow in the presence of Geneticin (G418) (GIBCO); transformed foci were scored after 2-3 weeks. Individual G418 colonies or transformed foci were isolated with the aid of cloning cylinders and maintained in Dulbecco's modified Eagle medium/10% calf serum. DNA Constructs. Human mAChRs genes (9-12) were inserted into an expression vector, pDS, which contained a dominant selectable marker, neo (20) . pDS v-fgr was derived from pSV2v-fgr, which contained the biologically active Gardner-Rasheed feline sarcoma virus proviral genome (21, 22) .
Analysis of Receptor Expression. Cell membranes were isolated, and binding was assayed as described (23 tTo whom reprint requests should be addressed.
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Proc. Natl. Acad. Sci. USA 88 (1991) tography by the method of Berridge et al. (24) . Ten concentrations ofcarbachol (50 nM-333 tuM) were used to determine ED50 and maximal responses. cAMP Assays. Transfected NIH 3T3 cells were grown to 90% confluence in 24-well plates. Medium was replaced with 0.25 ml of Eagle's medium/1 mM 3-isobutyl-l-methylxanthine containing experimental agents. The reaction was stopped after 10 min of incubation at room temperature by adding 0.25 ml of an ice-cold solution containing 0.1 M HCl and 1 mM CaCl2. cAMP levels were determined by using a Gammaflow automated RIA for acetylated cAMP (Atto Instruments, Potomac, MD).
RESULTS
Conditional Transformation of Certain mAChR Transfectants. Expression plasmids carrying each of the human mAChRs were transfected into NIH 3T3 cells, a murine fibroblast lacking endogenous mAChRs (18) . Expression of each mAChR gene was driven by the Moloney leukemia virus long terminal repeat, a potent transcriptional promoter in NIH 3T3 cells. The same constructs also contained a dominant selectable marker, neo (20) , that conferred resistance to Geneticin (G418), thereby permitting determination of transfection efficiencies. As shown in Table 1 , the number of G418-resistant colonies was nearly identical for all plasmid DNAs tested, except for mS, which was not further examined. In contrast, transforming activity varied widely among DNA constructs. The v-fgr oncogene (21, 22) efficiently induced focus formation, whereas mAChR transfectants appeared morphologically indistinguishable from parental NIH 3T3 or vector-transfected cells (Table 1) . However, when maintained in the presence of carbachol, a stable analog of acetylcholine, foci of transformation readily appeared in cultures transfected with ml or m3 but not with m2 or m4 mAChR genes (Table 1) . Focus formation increased as a function of agonist concentration (Table 1) , and carbacholinduced transformation was prevented by the muscarinic antagonist atropine (Fig. 1) .
Agonist Requirement for Maintenance of the Transformed State. To determine whether transformation of ml and m3 AChR transfectants required agonist for maintenance of their transformed state, foci were picked and replated on a lawn of untransfected NIH 3T3 cells in medium lacking carbachol. Human mAChRs genes or v-fgr were inserted into an expression vector, pDS, and 0.05-1 ,ug of plasmid DNA was transfected into NIH 3T3 murine fibroblasts (18) as described (19) . Media containing various concentrations of the muscarinic cholinergic agonist, carbachol, or the muscarinic cholinergic antagonist, atropine (10 gsM), were replaced every 2 days. Foci of transformation were scored after 2-3 weeks. Efficiency of transfection was determined by scoring neo-resistant colonies in medium containing G418 (0.750 mg/ml). Cultures were maintained in Dulbecco's modified Eagle's medium (A-C), supplemented with 100 jLM carbachol (D), 10 ,uM atropine (E), or 100 ,uM carbachol and 10 ,uM atropine in combination (F).
Plates were stained 3 weeks after transfection. Fig. 2 shows that under these conditions, cells returned to their nontransformed morphology. In contrast, foci arose when the culture medium was supplemented with carbachol. Furthermore, focus-derived cells could form large colonies in soft agar in the presence, but not in the absence, of agonist (data not shown). Thus, ml and m3 mAChR transfectants possessed properties of fully malignant cells. These findings showed that ml and m3 mAChRs were potent transforming agents and that agonist was required for induction and maintenance of malignant transformation.
Verification of mAChR Expression in NIH 3T3 Transfectants. To directly examine mAChR expression in transfected cells, several ml and m3 foci were cloned and evaluated for receptor expression by binding of a labeled nonselective mAChR antagonist, [3H]NMS. Receptor numbers were found to be higher in cloned ml and m3 foci as compared with parental Geneticin-selected mass cultures (Table 2 ). This finding suggested that high levels of receptor expression were required for transforming activity. Binding to m2-and m4-transfected mass cultures was similar to that for m3 transfectants (Table 2) . Thus, the lack of foci in m2-and m4-transfected cultures demonstrated an intrinsic difference between ml and m3 as compared with m2 and m4 mAChRs. We also investigated binding characteristics of mAChRs expressed in NIH 3T3 cells. Dissociation constants and total binding sites for representative G418-selected clones revealed Kd values of 63, 82, 38, and 26 pM for ml-m4 receptors, respectively. These affinities are nearly identical to those described in other cell lines (16, 17, 23 Quantitation of Transformation Induced by Carbachol. To explore quantitative aspects of transformation induced by activation of ml and m3 mAChRs, we devised an assay for ligand-dependent transformation that involved plating mAChR transfectants on a lawn of NIH 3T3 cells. Without carbachol, no foci of transformation were seen. However, when concentrations of the agonist from 100 nM to 1 mM were added to the culture medium, foci arose in <1 week in a clonal ml transfectant (Fig. 3) . Furthermore, the number of foci seen was directly proportional to, ligand concentration (Fig. 3, and see below) . At a carbachol concentration of 1 mM, 100lo of the ml transfectants plated gave rise to foci of transformation. Under these conditions as well, focus for- Second-Messenger Coupling in mAChR Transfectants. To determine whether mAChRs expressed in NIH 3T3 cells were coupled to second-messenger generation systems, transfectants were examined for known biochemical effects in response to agonist. Significant Ptdlns hydrolysis was seen in cells expressing ml or m3 receptors but not in m2 and m4 expressors, even at very high agonist concentration (Fig. 4) . Carbachol decreased cAMP levels only in forskolin-treated cells expressing m2 and m4 mAChRs (Fig. 4) (10 ,uM) prevented the carbacholdependent accumulation of 3H-labeled PtdIns (data not shown). Inhibition of adenylyl cyclase was determined by measuring the effect of carbachol on cAMP accumulation induced by forskolin, in the presence of isobutylmethylxanthine (100 ,uM). Cells, treated for 10 min with saline solution (bar 1) or 1 mM carbachol (bar 2), did not accumulate detectable cAMP. Treatment with 10 mM forskolin alone (bar 3) or in combination with 1 mM carbachol (bar 4) is also shown. cAMP was measured by RIA as described. *, P < 0.01 versus forskolin alone. Data are means ± SEM of three replicate determinations. WValues were too low to be determined with sufficient accuracy.
subtype for PtdIns hydrolysis and focus formation in response to various concentrations of agonist. As shown in Fig.  4 , we observed that curves for PtdIns hydrolysis were nearly superimposable upon those for focus formation. We then determined the half-maximal dose (EC5o) for both PtdIns hydrolysis and transformation by using several clonal transfectants selected for variations in receptor expression. For each clone examined, the half-maximal concentration of carbachol required for cell transformation was nearly identical to that necessary to stimulate PtdIns hydrolysis (Table  3) . Furthermore, the maximal PtdIns hydrolysis response was proportional to the number of mAChRs expressed by respective ml or m3 clonal transfectants.
Very few foci were seen in cells expressing low numbers of ml or m3 mAChR. In contrast, >95% of ml or m3 transfectants, binding >612 
DISCUSSION
The protein products of the mas oncogene and 5-hydroxytryptophan lc (serotonin) receptors are transforming in NIH 3T3 cells and are thought to be coupled to PtdIns hydrolysis (7, 8) . However, correlation between this biochemical response and transformation has not been directly demonstrated. Furthermore, overexpression of G protein-coupled receptors can overcome the specificity of coupling to second messengers (25, 26 (27) (28) (29) , and thus also to transformation. In the present study, we have shown that receptors actively inhibiting adenylyl cyclase do not induce focus formation or anchorage-independent growth, whereas stimulation of receptors coupled to Ptdlns hydrolysis are highly transforming. We have also shown that the cAMP response to forskolin was not decreased in cells expressing ml or m3 mAChRs. Thus, in contrast to previous suggestions (27) (28) (29) , our present findings establish that inhibition of adenylate cyclase is neither sufficient nor necessary for transformation of murine fibroblasts.
We cannot rule out the possibility that second messengers other than PtdIns hydrolysis may be involved in the transformation response seen. Activation of mAChRs may transform NIH 3T3 cells by coupling to arachidonic acid release and prostaglandin synthesis or by altering the behavior of ion channels (13) (14) (15) 17) . Alternatively, the ras oncogene product (a GTP-binding protein) has been suggested to alter G protein-coupled receptor functioning (30) (31) (32) , including m2 mAChR-mediated activation of cardiac K+ channels (33) . If so, a provocative linkage may exist between G proteincoupled receptors and p2lras. Finally, tyrosine phosphorylation, one of the hallmarks of oncogene-induced transformation, can be induced in neutrophils or platelets by chemotactic agents (34) or thrombin (35, 36) , respectively, both of which can activate G protein-coupled receptors (37) (38) (39) . Thus, further investigation will be required to determine the contributions of each of these various biochemical processes to malignant transformation.
Expression of mAChRs as well as other G protein-coupled receptors is limited to neurons or other terminally differentiated cells. In general, this family of receptors transduces signals involved in differentiated functions performed by mature cells. Thus, the transforming action of these receptors, when activated in fibroblasts, suggests that biochemical responses normally signaling differentiated functions might contribute to naturally occurring tumorigenesis when elicited in immature cells having proliferative capacity.
